GlobeNewswire

October 15, 2021 Off

Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

Initiated Phase 1 trial of lead CBL-B E3 ligase inhibitor program NX-1607 in patients with cancer Expanded Board of Directors…

October 15, 2021 Off

Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes

By GlobeNewswire

BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the…

October 15, 2021 Off

Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes

By GlobeNewswire

BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the…

October 15, 2021 Off

PAOG Announces Market Launch Of First CBD Nutraceutical To Take Place On Monday October 18th

By GlobeNewswire

Sandusky, OH, Oct. 14, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today announced the market launch of…

October 15, 2021 Off

PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease; PLx’s VAZALORE Specifically Indicated for Secondary Prevention

By GlobeNewswire

Aspirin remains an established practice for the prevention of another heart attack or clot-related strokeSPARTA, N.J., Oct. 14, 2021 (GLOBE…

October 15, 2021 Off

Todos Medical to Conduct Webinar Highlighting the cPass SARS-COV-2 Neutralizing Antibody Test for AMDA, The Society for Post-Acute and Long-Term Care Medicine, on October 22, 2021 at 12:00 PM EDT

By GlobeNewswire

Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the…

October 15, 2021 Off

Vaxil Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.

By GlobeNewswire

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) — VAXIL BIO…

October 15, 2021 Off

TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

By GlobeNewswire

New ULTIMATE I & II data presented at ECTRIMS shows ublituximab treatment is associated with significant improvement in the multiple…

October 13, 2021 Off

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

By GlobeNewswire

CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…

October 13, 2021 Off

Fireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

By GlobeNewswire

LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and…